Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Recent health news highlights various developments, including Trump's spending bill impacting insurance costs, a major acquisition in the bioscience sector, and GSK's efforts to expand RSV vaccine ...

Chinese biotech shares are surging this year on growing optimism over innovative cancer treatments being licensed to western ...

Health and Human Services Secretary Robert F. Kennedy Jr. lambasted federal agencies he accused of being overly influenced by ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Overview of Contraceptive Drugs MarketThe global Contraceptive Drugs Market is valued at USD 19.80 Billion in 2024 and is projected to reach a value of USD 49.75 Billion by 2035 at a CAGR (Compound ...

Zohran Mamdani said he would discourage the use of the slogan “globalize the intifada” in a roughly hourlong meeting with some of New York City’s most powerful executives on Tuesday, seeking to defuse ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Australia ‘undervalues’ the products of drug companies, Pfizer has told the Productivity Commission, echoing US lobbyists ...

These are three rock-solid dividend stocks you can buy now and confidently forget, knowing they’ll keep working for you year ...